Zacks Investment Research on MSN
GSK gets EU approval for expanded use of Nucala in COPD
GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for ...
By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...
Wave claimed GSK is handing back rights to the frontrunning program not because of questions about its potential, but because ...
GSK’s presence in immunology and inflammation is heavily oriented around respiratory drugs, but the company has been expanding its scope through business deals. The pharmaceutical giant is now adding ...
We recently published 13 Best ADR Stocks to Invest In. GSK plc (NYSE:GSK) is one of the best ADR stocks. GSK plc (NYSE:GSK) is one of the largest pharmaceutical companies in the world. The firm scored ...
About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results